A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Patient Reported Impact of Psoriasis and Desired Treatment Outcomes
Understanding the holistic impact is crucial to enabling patients to live more fulfilling lives. For this research presented at the 2025 Fall Clinical Dermatology Conference, 98 members of MyPsoriasisTeam living with psoriasis were interviewed to better understand patient-desired outcomes and help dermatologists develop more effective approaches to treatment. The emotional toll of psoriasis manifests in […]
[email protected], CEO and founder of Swoop is a proud recipient of MM+M’s Pinnacle Award for his work furthering real world data and ML/AI in health marketing.
W2O acquires Swoop, the leader in AI generated digital health audiences trusted by 42 of the top 50 brands & 18 of the top 20 healthcare marketing agencies